×
About 7,466 results

ALLMedicine™ Bronchiectasis Center

Research & Reviews  3,651 results

Association of low fat mass with nontuberculous mycobacterial infection in patients wit...
https://doi.org/10.1097/MD.0000000000025193
Medicine Lim SY, Lee YJ et. al.

Apr 9th, 2021 - The incidence of pulmonary nontuberculous mycobacterial (NTM) infection is high in patients with underlying lung disease such as bronchiectasis. Although previous studies have reported many risk factors contributing to the development of NTM-lung ...

Favorable Response to Long-Term Azithromycin Therapy in Bronchiectasis Patients with Ch...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019603
International Journal of Chronic Obstructive Pulmonary Di... Choi Y, Shin SH et. al.

Apr 9th, 2021 - Long-term macrolide treatment is recommended for patients with chronic obstructive pulmonary disease (COPD) with frequent exacerbations. Bronchiectasis is a common comorbid condition in patients with COPD, for which long-term azithromycin is effec...

Sedentary time in people with obstructive airway diseases.
https://doi.org/10.1016/j.rmed.2021.106367
Respiratory Medicine; Cordova-Rivera L, Gardiner PA et. al.

Apr 8th, 2021 - Sedentary time (ST) and light-intensity physical activity (LIPA) are movement behaviours associated with important health outcomes, but are not widely explored in respiratory diseases. We aimed to describe their volume and/or accumulation patterns...

Integrative microbiomics in bronchiectasis exacerbations.
https://doi.org/10.1038/s41591-021-01289-7 10.1164/rccm.201711-2202OC 10.1016/S0140-6736(18)31767-7 10.1038/s41572-018-0042-3 10.1016/S2214-109X(19)30311-0 10.1038/s41598-019-42862-y 10.1016/S2213-2600(14)70213-9 10.1513/AnnalsATS.201310-335OC 10.1183/13993003.00766-2018 10.1186/s12890-018-0636-2 10.1371/journal.pone.0170622 10.1183/16000617.0108-2018 10.1164/rccm.201807-1355OC 10.1016/S2213-2600(18)30053-5 10.1186/s12915-019-0703-z 10.1183/13993003.01953-2017 10.1371/journal.pcbi.1002606 10.1016/j.tim.2016.11.008 10.1016/S2213-2600(19)30185-7 10.1164/rccm.201809-1651OC 10.1016/S2213-2600(19)30191-2 10.1136/thoraxjnl-2016-209180 10.1183/16000617.0041-2019 10.1016/S2213-2600(18)30510-1 10.1183/13993003.01930-2017 10.1183/13993003.01899-2015 10.1164/rccm.200708-1151OC 10.1183/13993003.00242-2018 10.1183/13993003.00810-2018 10.3390/ijms20204991 10.1038/nature23480 10.1038/s41467-018-03157-4 10.1164/rccm.201309-1575OC 10.1183/09031936.00138707 10.1183/09031936.04.00014304 10.1183/13993003.00051-2017 10.1378/chest.09-2996 10.1164/rccm.201203-0478OC 10.1371/journal.pone.0060811 10.1016/j.mimet.2016.09.002 10.1128/mSystems.00140-17 10.1093/nar/gks808 10.1128/AEM.03006-05 10.1111/mec.12481 10.1128/AEM.00062-07 10.1038/nmeth.2810 10.3389/fgene.2019.00995 10.1038/s41368-019-0045-2 10.1038/s41467-019-12798-y 10.1073/pnas.1000087107 10.1101/gr.1239303 10.1186/s12885-019-6235-7 10.1073/pnas.1908493116 10.1093/bioinformatics/btu170 10.1038/nmeth.1923 10.1093/bioinformatics/btp352 10.1093/bioinformatics/btq033 10.1093/bioinformatics/btp450 10.1093/nar/28.1.27 10.1186/1471-2105-9-386 10.1016/j.chom.2019.09.009 10.1093/bioinformatics/btv033 10.1186/s40168-017-0283-5 10.1038/nmeth.3103 10.1183/13993003.00418-2020 10.1177/00131640021970871 10.1186/gb-2011-12-6-r60 10.1186/s12859-015-0863-y
Nature Medicine; Mac Aogáin M, Narayana JK et. al.

Apr 6th, 2021 - Bronchiectasis, a progressive chronic airway disease, is characterized by microbial colonization and infection. We present an approach to the multi-biome that integrates bacterial, viral and fungal communities in bronchiectasis through weighted si...

Exercise training for bronchiectasis.
https://doi.org/10.1002/14651858.CD013110.pub2
The Cochrane Database of Systematic Reviews; Lee AL, Gordon CS et. al.

Apr 6th, 2021 - Bronchiectasis is characterised by excessive sputum production, chronic cough, and acute exacerbations and is associated with symptoms of dyspnoea and fatigue, which reduce exercise tolerance and impair quality of life. Exercise training in isolat...

see more →

Guidelines  9 results

British Thoracic Society Guideline for bronchiectasis in adults.
https://doi.org/10.1136/thoraxjnl-2018-212463
Thorax Hill AT, Sullivan AL et. al.

Dec 13th, 2018 - British Thoracic Society Guideline for bronchiectasis in adults.|2018|Hill AT,Sullivan AL,Chalmers JD,De Soyza A,Elborn SJ,|methods,therapeutic use,diagnosis,therapy,methods,methods,

Treating Cough Due to Non-CF and CF Bronchiectasis With Nonpharmacological Airway Clearance
https://journal.chestnet.org/article/S0012-3692(18)30091-6/fulltext
CHEST

Jan 16th, 2018 - In bronchiectasis due to cystic fibrosis (CF) and other causes, airway clearance is one of the mainstays of management. We conducted a systematic review on airway clearance by using non-pharmacological methods as recommended by international guide...

European Respiratory Society guidelines for the management of adult bronchiectasis.
https://doi.org/10.1183/13993003.00629-2017
The European Respiratory Journal; Polverino E, Goeminne PC et. al.

Sep 10th, 2017 - Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent exacerbations in many patients. There have been no previous international guidelines.The European Respiratory Society guidelines for the management of...

Guidelines for the management of adult lower respiratory tract infections--summary.
https://doi.org/10.1111/j.1469-0691.2011.03602.x
Clinical Microbiology and Infection : the Official Public... Woodhead M, Blasi F et. al.

Nov 1st, 2011 - This document is an update of Guidelines published in 2005 and now includes scientific publications through to May 2010. It provides evidence-based recommendations for the most common management questions occurring in routine clinical practice in ...

Guidelines for the management of adult lower respiratory tract infections--full version.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128977
Clinical Microbiology and Infection : the Official Public... Woodhead M, Blasi F et. al.

Nov 1st, 2011 - This document is an update of Guidelines published in 2005 and now includes scientific publications through to May 2010. It provides evidence-based recommendations for the most common management questions occurring in routine clinical practice in ...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  3,707 results

Association of low fat mass with nontuberculous mycobacterial infection in patients wit...
https://doi.org/10.1097/MD.0000000000025193
Medicine Lim SY, Lee YJ et. al.

Apr 9th, 2021 - The incidence of pulmonary nontuberculous mycobacterial (NTM) infection is high in patients with underlying lung disease such as bronchiectasis. Although previous studies have reported many risk factors contributing to the development of NTM-lung ...

Favorable Response to Long-Term Azithromycin Therapy in Bronchiectasis Patients with Ch...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019603
International Journal of Chronic Obstructive Pulmonary Di... Choi Y, Shin SH et. al.

Apr 9th, 2021 - Long-term macrolide treatment is recommended for patients with chronic obstructive pulmonary disease (COPD) with frequent exacerbations. Bronchiectasis is a common comorbid condition in patients with COPD, for which long-term azithromycin is effec...

Sedentary time in people with obstructive airway diseases.
https://doi.org/10.1016/j.rmed.2021.106367
Respiratory Medicine; Cordova-Rivera L, Gardiner PA et. al.

Apr 8th, 2021 - Sedentary time (ST) and light-intensity physical activity (LIPA) are movement behaviours associated with important health outcomes, but are not widely explored in respiratory diseases. We aimed to describe their volume and/or accumulation patterns...

Integrative microbiomics in bronchiectasis exacerbations.
https://doi.org/10.1038/s41591-021-01289-7 10.1164/rccm.201711-2202OC 10.1016/S0140-6736(18)31767-7 10.1038/s41572-018-0042-3 10.1016/S2214-109X(19)30311-0 10.1038/s41598-019-42862-y 10.1016/S2213-2600(14)70213-9 10.1513/AnnalsATS.201310-335OC 10.1183/13993003.00766-2018 10.1186/s12890-018-0636-2 10.1371/journal.pone.0170622 10.1183/16000617.0108-2018 10.1164/rccm.201807-1355OC 10.1016/S2213-2600(18)30053-5 10.1186/s12915-019-0703-z 10.1183/13993003.01953-2017 10.1371/journal.pcbi.1002606 10.1016/j.tim.2016.11.008 10.1016/S2213-2600(19)30185-7 10.1164/rccm.201809-1651OC 10.1016/S2213-2600(19)30191-2 10.1136/thoraxjnl-2016-209180 10.1183/16000617.0041-2019 10.1016/S2213-2600(18)30510-1 10.1183/13993003.01930-2017 10.1183/13993003.01899-2015 10.1164/rccm.200708-1151OC 10.1183/13993003.00242-2018 10.1183/13993003.00810-2018 10.3390/ijms20204991 10.1038/nature23480 10.1038/s41467-018-03157-4 10.1164/rccm.201309-1575OC 10.1183/09031936.00138707 10.1183/09031936.04.00014304 10.1183/13993003.00051-2017 10.1378/chest.09-2996 10.1164/rccm.201203-0478OC 10.1371/journal.pone.0060811 10.1016/j.mimet.2016.09.002 10.1128/mSystems.00140-17 10.1093/nar/gks808 10.1128/AEM.03006-05 10.1111/mec.12481 10.1128/AEM.00062-07 10.1038/nmeth.2810 10.3389/fgene.2019.00995 10.1038/s41368-019-0045-2 10.1038/s41467-019-12798-y 10.1073/pnas.1000087107 10.1101/gr.1239303 10.1186/s12885-019-6235-7 10.1073/pnas.1908493116 10.1093/bioinformatics/btu170 10.1038/nmeth.1923 10.1093/bioinformatics/btp352 10.1093/bioinformatics/btq033 10.1093/bioinformatics/btp450 10.1093/nar/28.1.27 10.1186/1471-2105-9-386 10.1016/j.chom.2019.09.009 10.1093/bioinformatics/btv033 10.1186/s40168-017-0283-5 10.1038/nmeth.3103 10.1183/13993003.00418-2020 10.1177/00131640021970871 10.1186/gb-2011-12-6-r60 10.1186/s12859-015-0863-y
Nature Medicine; Mac Aogáin M, Narayana JK et. al.

Apr 6th, 2021 - Bronchiectasis, a progressive chronic airway disease, is characterized by microbial colonization and infection. We present an approach to the multi-biome that integrates bacterial, viral and fungal communities in bronchiectasis through weighted si...

Exercise training for bronchiectasis.
https://doi.org/10.1002/14651858.CD013110.pub2
The Cochrane Database of Systematic Reviews; Lee AL, Gordon CS et. al.

Apr 6th, 2021 - Bronchiectasis is characterised by excessive sputum production, chronic cough, and acute exacerbations and is associated with symptoms of dyspnoea and fatigue, which reduce exercise tolerance and impair quality of life. Exercise training in isolat...

see more →

News  91 results

Safety of JAK Inhibitors vs Rituximab in Patients with RA and Pulmonary Disease
https://www.medscape.com/viewarticle/947663

Mar 17th, 2021 - Takeaway Janus kinase (JAK) inhibition with baricitinib or tofacitinib for the treatment of rheumatoid arthritis (RA) in patients with concurrent interstitial lung disease (ILD) or bronchiectasis did not increase the rate of hospitalisation or dea...

Novel Agent Shows Promise in Bronchiectasis
https://www.medscape.com/viewarticle/933610

Jul 7th, 2020 - Brensocatib, an experimental small-molecule inhibitor targeted to inflammation-regulating neutrophil serine proteases, may be a novel, nonantibiotic option for reducing exacerbations in patients with bronchiectasis, investigators in the phase 2 WI...

Fast Five Quiz: How Much Do You Know About COPD?
https://reference.medscape.com/viewarticle/865477_3

May 26th, 2020 - In a multicenter, prospective, observational study of 201 consecutive patients with moderate-to-severe COPD, Martinez-Garcia and colleagues reported that in addition to smoking, pulmonary hypertension, and declining lung function, all of which are...

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Imaging
https://reference.medscape.com/viewarticle/925458_2

Apr 29th, 2020 - Figure 1. Colored x-ray, idiopathic pulmonary fibrosis The usual interstitial pneumonia (UIP) pattern on high-resolution CT (HRCT) scan is described as honeycombing with or without traction bronchiectasis and subpleural with basal predominance. Le...

Amoxicillin/clavulanate emerges as best antibiotic for childhood bronchiectasis
https://www.mdedge.com/clinicianreviews/article/210387/pulmonology/amoxicillin/clavulanate-emerges-best-antibiotic?channel=271
Ted Bosworth

Oct 18th, 2019 - MADRID – A placebo-controlled trial has confirmed that amoxicillin/clavulanate is beneficial for resolution of acute exacerbations in nonsevere bronchiectasis while also demonstrating a greater relative effect than azithromycin, based on data pres.

see more →

Patient Education  3 results see all →